15don MSN
Autologous T cell therapy targeting multiple antigens shows promise in treating pancreatic cancer
A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising results in a first in-human phase 1/2 trial.
Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...
Trojan horse” approach may enable ‘antigen-independent’ therapy with potential to treat cancers not traditionally amenable to immunotherapy.
For years, cell and gene therapies were mainly associated with rare and orphan diseases, those that impact small patient groups and lack effective treatment options. However, recent developments in ...
Actor Abhay Deol has revealed undergoing stem cell therapy in South Korea to treat chronic knee pain and sciatica caused by a ...
Even with breakthroughs, treatment for advanced squamous cell carcinoma is more complex. Patients often need more than one treatment. Many patients with this advanced cancer are cared for by a team of ...
Raw materials play a critical role in cell therapy manufacturing. Choosing suboptimal materials at any stage of development ...
Cabaletta Bio (CABA) advances engineered cell therapies for autoimmune disease; insider buying boosts confidence. Click here ...
Q. I am a 45-year-old competitive racquetball player who has had six months of right shoulder pain. The pain is worst on overhead motions while playing. The discomfort also wakes me at night. An MRI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results